I was educated and trained at
Columbia University College of Physicians and Surgeons, NY
New York Medical College, 1986-88
Mt. Sinai Medical Center, NY NY, 1988-89
Clinical Professor of Medicine, Columbia University
I'm affiliated with
New york and presbyterian hospital
Columbia Presbyterian Med Ctr
New York Presbyterian Hospital
NY Presbyterian-Columbia, New York NY
Dr. Gerald Neuberg
I've won the following awards
Top Cardiologist , New York
Alpha Omega Alpha 1983
Castle Connolly Guide: Top Doctor, NY Metro, 1996-present
VHA National Clinical Excellence Award for infection control in Allen ICU, 2008
Teacher of the Year Award, Columbia Dept of Family Medicine, 2008
Ewig Clinical Scholar Award, Columbia University Dept of Medicine, 2010
Leonard Tow Award for Humanism in Medicine, Gold Foundation, 2012
Reduced lymphocyte stimulatory guanine nucleotide regulatory protein and beta-adrenergic receptors in congestive heart failure and reversal with angiotensin converting enzyme inhibitor therapy.
Circulation., Dec;78(6):1373-9 (1988)
The current status of angiotensin converting enzyme inhibitors in the management of patients with chronic heart failure.
J Hypertens Suppl., Sep;7(5):S33-6 (1989)
Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group.
N. Engl. J. Med., Oct;335(15):1107-14 (1996)
Diuretic resistance predicts mortality in patients with advanced heart failure.
Am. Heart J., Jul;144(1):31-8 (2002)
The cost of end-of-life care: a new efficiency measure falls short of AHA/ACC standards.
Circ Cardiovasc Qual Outcomes., Mar;2(2):127-33 (2009)
Cardiopulmonary exercise testing. The clinical value of gas exchange data.
Arch. Intern. Med., Oct;148(10):2221-6 (1988)
Circadian rhythm and sudden death in heart failure: results from Prospective Randomized Amlodipine Survival Trial.
J. Am. Coll. Cardiol., Aug;36(2):541-6 (2000)
Effect of amlodipine on mode of death among patients with advanced heart failure in the PRAISE trial. Prospective Randomized Amlodipine Survival Evaluation.
Am. J. Cardiol., Oct;82(7):881-7 (1998)
Lymphocyte G proteins reflect response to treatment in congestive heart failure.
Am. Heart J., Jan;129(1):98-106 (1995)
Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).
Circulation., Aug;88(2):492-501 (1993)
Hemodynamic effects of renin inhibition by enalkiren in chronic congestive heart failure.
Am. J. Cardiol., Jan;67(1):63-6 (1991)